Periscope Capital’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Periscope Capital’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$16.5K	–	532
2023 Q3	$16.5K	Sell	100,000 -525,091	-84%	-$121K	﹤0.01%	490
2023 Q2	$97.1K	Hold	625,091	–	–	0.01%	365
2023 Q1	$47.5K	Buy	625,091 +24,016	+4%	+$1.63K	﹤0.01%	543
2022 Q4	$36.5K	Buy	601,075 +343,175	+133%	+$28.1K	﹤0.01%	610
2022 Q3	$18K	Hold	257,900	–	–	﹤0.01%	901
2022 Q2	$26K	Hold	257,900	–	–	﹤0.01%	865
2022 Q1	$90K	Hold	257,900	–	–	﹤0.01%	792
2021 Q4	$171K	Buy	257,900 +58,200	+29%	+$39K	﹤0.01%	730
2021 Q3	$137K	Buy	+199,700	New	+$160K	﹤0.01%	711

Other funds holding AONCW

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Periscope Capital's AONCW Position: Q4 2023 in Review

Periscope Capital sold out of American Oncology Network, Inc. Warrant (AONCW) in Q4 2023, closing a stake of 100,000 shares — an estimated $16.5K sold.

Periscope Capital first reported a position in AONCW in Q3 2021 and held it in 9 quarters. The position peaked at $171K in Q4 2021. 32 funds tracked by Wall St. Rank hold AONCW as of Q4 2023.

Periscope Capital reported no remaining American Oncology Network, Inc. Warrant position as of Q4 2023 after selling out during the quarter.
Periscope Capital sold 100,000 American Oncology Network, Inc. Warrant shares in Q4 2023, an estimated $16.5K.
Periscope Capital first reported a position in American Oncology Network, Inc. Warrant in Q3 2021 and held it in 9 quarters.
Periscope Capital's American Oncology Network, Inc. Warrant position peaked at $171K in Q4 2021.
32 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q4 2023.

Based on Periscope Capital's 13F filing for Q4 2023, filed 13 Feb 2024.